Literature DB >> 22892659

[Intraoperative frozen section diagnosis of the genitourinary tract].

S Bertz1, B J Schmitz-Dräger, C Protzel, A Hartmann.   

Abstract

Up to now intraoperative frozen section, diagnosis has been of limited utility in urologic oncology. In the future, it may become more important due to a significant increase in the number of nerve-sparing operations performed for prostate cancer. Accuracy and benefit of intraoperative frozen sections depend both on a good communication between surgeons and pathologists as well as on a strict assessment of the need for surgery in the individual patient. In order to optimize cost-efficiency and to reduce the associated risks the indications for intraoperative frozen sections must be rigorously appraised. This report outlines clinically relevant indications for intraoperative frozen section diagnosis in tumors of the urinary tract, kidneys, prostate, testis and penis according to the most recent guidelines. The diagnostic scope and problems of this method are also discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22892659     DOI: 10.1007/s00292-012-1600-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  19 in total

1.  Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.

Authors:  Edward M Messing; Judith Manola; Jorge Yao; Maureen Kiernan; David Crawford; George Wilding; P Anthony di'SantAgnese; Donald Trump
Journal:  Lancet Oncol       Date:  2006-06       Impact factor: 41.316

2.  Nephron sparing surgery for renal cell carcinoma 4 cm. or less in diameter: indicated or under treated?

Authors:  H Wunderlich; O Reichelt; S Schumann; A Schlichter; H Kosmehl; W Werner; R Vollandt; J Schubert
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

3.  Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversity.

Authors:  David L Wachter; Peter H Wünsch; Arndt Hartmann; Abbas Agaimy
Journal:  Virchows Arch       Date:  2011-02-20       Impact factor: 4.064

4.  Potential pitfalls in the frozen section evaluation of parenchymal margins in nephron-sparing surgery.

Authors:  Teresa McHale; S Bruce Malkowicz; John E Tomaszewski; Elizabeth M Genega
Journal:  Am J Clin Pathol       Date:  2002-12       Impact factor: 2.493

5.  Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience.

Authors:  Bin K Kroon; Simon Horenblas; Willem Meinhardt; Henk G van der Poel; Axel Bex; Harm van Tinteren; Renato A Valdés Olmos; Omgo E Nieweg
Journal:  Eur Urol       Date:  2005-01-22       Impact factor: 20.096

6.  Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less.

Authors:  Max Kates; Gina M Badalato; Max Pitman; James M McKiernan
Journal:  J Urol       Date:  2011-08-17       Impact factor: 7.450

7.  Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience.

Authors:  C A Pettaway; L L Pisters; C P Dinney; F Jularbal; D A Swanson; A C von Eschenbach; A Ayala
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

8.  Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis.

Authors:  Vincenzo Ficarra; Guido Martignoni; Nicola Maffei; Maria Angela Cerruto; Giacomo Novara; Stefano Cavalleri; Walter Artibani
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.

Authors:  Martin C Schumacher; Fiona C Burkhard; George N Thalmann; Achim Fleischmann; Urs E Studer
Journal:  Eur Urol       Date:  2008-05-21       Impact factor: 20.096

10.  Intraoperative frozen section analysis during nerve sparing laparoscopic radical prostatectomy: feasibility study.

Authors:  Gaëlle Fromont; Hervé Baumert; Xavier Cathelineau; François Rozet; Pierre Validire; Guy Vallancien
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.